WorldPing logo WorldPing← All news

More Than 1 Million Americans Are Taking Ozempic and Other GLP-1s Without an Approved Reason. Is That Actually a Problem?

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: Gizmodo
More Than 1 Million Americans Are Taking Ozempic and Other GLP-1s Without an Approved Reason. Is That Actually a Problem?WorldPing
Image via Gizmodo.

What happened

New research shows that off-label use of GLP-1s has surged in recent years.

Key facts

  • New research shows that off-label use of GLP-1s has surged in recent years.
  • Reported by Gizmodo and published Thu, 24 Sep 2026 16:50:11 UTC.

Why it matters

Platform, chip and AI decisions set the terms other companies have to build on, so a single announcement here tends to ripple through products, supply chains and regulation.

What to watch next

  • Availability, pricing and rollout regions
  • Independent testing or verification of the claims made
  • Responses from regulators and competing platforms

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. How to get your cut of Apple's $250 million Siri settlement

  2. Qualcomm Hops on the Linux Train as PC Users Have Another Way to Say ‘Screw Windows’

  3. 2 days left to save up to $200 on a TechCrunch Disrupt 2026 pass — reason 4 of 5 to attend

  4. Reddit mod ordered to pay Nintendo $4.5 million in Switch piracy lawsuit

  5. More Than 1 Million Americans Are Taking Ozempic and Other GLP-1s Without an Approved Reason. Is That Actually a Problem?

Sources

The original report was published by Gizmodo. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at Gizmodo

Related WorldPing coverage